4.605
Finanzdaten der Prime Medicine Inc-Aktie (PRME)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
23.31%
1.115
|
1.454 | 2.183 | 0.209 | - |
|
|
1.20%
54.49
|
53.85 | 46.41 | 54.44 | 55.67 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
1.20%
54.49
|
53.85 | 46.41 | 54.44 | 55.67 |
| Operating Income/Loss |
1.88%
-53.38
|
-52.39 | -44.22 | -54.23 | -55.67 |
| Nonoperating Income/Loss |
56.57%
0.786
|
0.502 | 1.946 | 1.714 | 0.211 |
| Income/Loss From Continuing Operations Before Tax |
102.15%
1.115
|
-51.89 | 2.183 | 0.209 | -55.33 |
| Income Tax Expense/Benefit, Deferred |
-
|
- | - | - | -0.134 |
| Income Tax Expense/Benefit |
-
|
- | - | - | -0.134 |
| Income/Loss From Continuing Operations After Tax |
1.35%
-52.59
|
-51.89 | -42.28 | -52.52 | -55.33 |
|
|
1.35%
-52.59
|
-51.89 | -42.28 | -52.52 | -55.33 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.30%
129.19
|
130.88 | 4.108 | 119.76 | 119.19 |
| Diluted Average Shares |
1.30%
129.19
|
130.88 | 4.108 | 119.76 | 119.19 |
| Basic Earnings Per Share |
2.50%
-0.41
|
-0.40 | -0.31 | -0.44 | -0.46 |
| Diluted Earnings Per Share |
2.50%
-0.41
|
-0.40 | -0.31 | -0.44 | -0.46 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):